Elix Provides AI Drug Discovery Platform "Elix Discovery™" to KYORIN Pharmaceutical
TOKYO, JAPAN, August 20, 2025 /EINPresswire.com/ -- Elix, Inc. (CEO: Shinya Yuki / Headquarters: Tokyo; hereinafter “Elix”), a Japan-based AI drug discovery company, is pleased to announce that KYORIN Pharmaceutical Co., Ltd. (Headquarters: …